Sanavia Oncology
Founded 2020 · 14 employees on LinkedIn · 1 known investors
Find your way into Sanavia Oncology
Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.
Investors · 1
In the news
Frequently asked questions
- What does Sanavia Oncology do?
- Sanavia discovers novel cancer-specific epitopes using proprietary immunization technology and AI to enable more effective antibody therapies for oncology. The company develops epitope discovery platforms and antibody drug candidates targeting multiple cancer types to expand treatment options for patients.
- Who are Sanavia Oncology's investors?
- Sanavia Oncology's investors include Two Bear Capital.